BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 33200567)

  • 21. Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia.
    Trobec K; Palus S; Tschirner A; von Haehling S; Doehner W; Lainscak M; Anker SD; Springer J
    Nutrition; 2014 Sep; 30(9):1069-75. PubMed ID: 24976415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycine administration attenuates skeletal muscle wasting in a mouse model of cancer cachexia.
    Ham DJ; Murphy KT; Chee A; Lynch GS; Koopman R
    Clin Nutr; 2014 Jun; 33(3):448-58. PubMed ID: 23835111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IFIT2-depleted metastatic oral squamous cell carcinoma cells induce muscle atrophy and cancer cachexia in mice.
    Lai KC; Hong ZX; Hsieh JG; Lee HJ; Yang MH; Hsieh CH; Yang CH; Chen YR
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1314-1328. PubMed ID: 35170238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice.
    Kandarian SC; Nosacka RL; Delitto AE; Judge AR; Judge SM; Ganey JD; Moreira JD; Jackman RW
    J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1109-1120. PubMed ID: 30270531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physiologic and molecular characterization of a novel murine model of metastatic head and neck cancer cachexia.
    Olson B; Norgard MA; Levasseur PR; Zhu X; Marks DL
    J Cachexia Sarcopenia Muscle; 2021 Oct; 12(5):1312-1332. PubMed ID: 34231343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tandospirone reduces wasting and improves cardiac function in experimental cancer cachexia.
    Elkina Y; Palus S; Tschirner A; Hartmann K; von Haehling S; Doehner W; Mayer U; Coats AJ; Beadle J; Anker SD; Springer J
    Int J Cardiol; 2013 Dec; 170(2):160-6. PubMed ID: 24207070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism.
    Pin F; Barreto R; Couch ME; Bonetto A; O'Connell TM
    J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):140-154. PubMed ID: 30680954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The complex heterogeneity of immune cell signatures across wasting tissues with C26 and 5-fluorouracil-induced cachexia.
    VanderVeen BN; Cardaci TD; Bullard BM; Huss AR; McDonald SJ; Muhammed AD; Kubinak JL; Fan D; Murphy EA
    Am J Physiol Cell Physiol; 2024 Feb; 326(2):C606-C621. PubMed ID: 38189130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D repletion ameliorates adipose tissue browning and muscle wasting in infantile nephropathic cystinosis-associated cachexia.
    Cheung WW; Hao S; Wang Z; Ding W; Zheng R; Gonzalez A; Zhan JY; Zhou P; Li S; Esparza MC; Hoffman HM; Lieber RL; Mak RH
    J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):120-134. PubMed ID: 31721480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptide-2 from mouse myostatin precursor protein alleviates muscle wasting in cancer-associated cachexia.
    Ojima C; Noguchi Y; Miyamoto T; Saito Y; Orihashi H; Yoshimatsu Y; Watabe T; Takayama K; Hayashi Y; Itoh F
    Cancer Sci; 2020 Aug; 111(8):2954-2964. PubMed ID: 32519375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival.
    Zhou X; Wang JL; Lu J; Song Y; Kwak KS; Jiao Q; Rosenfeld R; Chen Q; Boone T; Simonet WS; Lacey DL; Goldberg AL; Han HQ
    Cell; 2010 Aug; 142(4):531-43. PubMed ID: 20723755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia.
    Bonetto A; Rupert JE; Barreto R; Zimmers TA
    J Vis Exp; 2016 Nov; (117):. PubMed ID: 27929469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of cachexia in the human fibrosarcoma HT-1080 mouse tumour model.
    Bernardo B; Joaquim S; Garren J; Boucher M; Houle C; LaCarubba B; Qiao S; Wu Z; Esquejo RM; Peloquin M; Kim H; Breen DM
    J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1813-1829. PubMed ID: 32924335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The protective effect of cannabinoids against colorectal cancer cachexia through modulation of inflammation and immune responses.
    Ng SK; Chung DJ; Chang LC; Luo CK; Jwo SH; Lee YH; Lin JS; Wang CH; Wei TT
    Biomed Pharmacother; 2023 May; 161():114467. PubMed ID: 36871538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of Akt-mTORC1 signalling reverts cancer-dependent muscle wasting.
    Geremia A; Sartori R; Baraldo M; Nogara L; Balmaceda V; Dumitras GA; Ciciliot S; Scalabrin M; Nolte H; Blaauw B
    J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):648-661. PubMed ID: 34741441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid atrophy of cardiac left ventricular mass in patients with non-small cell carcinoma of the lung.
    Kazemi-Bajestani SMR; Becher H; Butts C; Basappa NS; Smylie M; Joy AA; Sangha R; Gallivan A; Kavsak P; Chu Q; Baracos VE
    J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1070-1082. PubMed ID: 31293070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic blockade of ACVR2B ligands prevents chemotherapy-induced muscle wasting by restoring muscle protein synthesis without affecting oxidative capacity or atrogenes.
    Nissinen TA; Degerman J; Räsänen M; Poikonen AR; Koskinen S; Mervaala E; Pasternack A; Ritvos O; Kivelä R; Hulmi JJ
    Sci Rep; 2016 Sep; 6():32695. PubMed ID: 27666826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice.
    Brown JL; Rosa-Caldwell ME; Lee DE; Blackwell TA; Brown LA; Perry RA; Haynie WS; Hardee JP; Carson JA; Wiggs MP; Washington TA; Greene NP
    J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):926-938. PubMed ID: 28845591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.
    Murphy KT; Chee A; Gleeson BG; Naim T; Swiderski K; Koopman R; Lynch GS
    Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R716-26. PubMed ID: 21677277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. STAT3 in the systemic inflammation of cancer cachexia.
    Zimmers TA; Fishel ML; Bonetto A
    Semin Cell Dev Biol; 2016 Jun; 54():28-41. PubMed ID: 26860754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.